Results 21 to 30 of about 97,617 (323)

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. [PDF]

, 2014
peer reviewedOBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease.
Alfonso, Fernando, Clemmensen, Peter M, Collet, Jean-Philippe, Cremer, Jochen, da Costa, Bruno R, daCosta, Bruno R, Di Nisio, Marcello, Falk, Volkmar, Filippatos, Gerasimos, Hamm, Christian, Head, Stuart, Juni, Peter, Jüni, Peter, Kappetein, Arie Pieter, Kastrati, Adnan, Knuuti, Juhani, Kolh, Philippe, Landmesser, Ulf, Laufer, Günther, Maione, Ausilia, Neumann, Franz-Joseph, Richter, Dimitri, Rutjes, Anne Wilhelmina, Schauerte, Patrick, Siletta, Maria G, Silletta, Maria G, Sousa Uva, Miguel, Stefanini, Giulio G, Stortecky, Stefan, Taggart, David P, Torracca, Lucia, Valgimigli, Marco, Wijns, William, Windecker, Stephan, Witkowski, Adam   +34 more
core   +3 more sources

A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]

, 2016
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L., Kennedy, Simon, McCormick, Christopher, Mullen, Alexander B., Wadsworth, Roger M.   +4 more
core   +2 more sources

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger, Boeckstegers, Peter, Heitzer, Thomas, Hoffmann, Rainer, Köster, Ralf, Pohl, Tilmann   +5 more
core   +2 more sources

Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]

, 2012
Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A, Koppensteiner, Renate, Lammer, Johannes, Mellon, Rajeev M, Scheinert, Dierk, Schroë, Herman, Schwartz, Lewis B, Vermassen, Frank   +7 more
core   +2 more sources

An Analysis of Cost-Effectiveness of Stents Used in the Treatment of Coronary Artery Disease

Balkan Medical Journal, 2019
Background: There is only limited information about the cost-effectiveness of drug-eluting stents compared with bare-metal stents in Turkey. Aims: To evaluate bare-metal and drug-eluting stents used in the treatment of coronary artery disease from the ...
Ferda Işıkçelik, İsmail Ağırbaş, Cansın Tulunay Kaya   +2 more
doaj   +1 more source

Outcomes of supraflex Sirolimus-eluting coronary stents

Current Medical Issues, 2022
Background: The development of a sirolimus-eluting coronary stent (SES) was a big step forward in interventional cardiology. SES has been demonstrated in large, randomized clinical studies to reduce angiographic restenosis and target vessel ...
Vishal Virendra Singh, Sheikh Mohamad Tahir, Sanjiv Sharma   +2 more
doaj   +1 more source

Safety of short-term dual antiplatelet therapy after drug-eluting stents:An updated meta-analysis with direct and adjusted indirect comparison of randomized control trials [PDF]

, 2014
Background: Duration of dual antiplatelet therapy (DAPT) following drug-eluting stents (DES) remains controversial and is a topic of ongoing research.
Bulluck, Heerajnarain, Kwok, Chun Shing, Loke, Yoon K., Ryding, Alisdair D.   +3 more
core   +1 more source

Investigations into the characterization, degradation, and applications of biodegradable polymers by mass spectrometry

Mass Spectrometry Reviews, EarlyView., 2023
Abstract Biodegradable polymers have been getting more and more attention because of their contribution to the plastic pollution environmental issues and to move towards a circular economy. Nevertheless, biodegradable materials still exhibit various disadvantages restraining a widespread use in the market.
Paola Rizzarelli, Melania Leanza, Marco Rapisarda   +2 more
wiley   +1 more source

Restenosis of Drug-Eluting Stents.

Circulation. Cardiovascular Interventions, 2019
Despite on-going evolution and iteration of drug-eluting stent (DES) technology, the prevalence of in-stent restenosis (ISR) remains relatively unchanged, encompassing ≈10% of percutaneous coronary interventions.
Evan Shlofmitz, M. Iantorno, R. Waksman
semanticscholar   +1 more source

Design and testing of hydrophobic core/hydrophilic shell nano/micro particles for drug-eluting stent coating [PDF]

, 2018
In this study, we designed a novel drug-eluting coating for vascular implants consisting of a core coating of the anti-proliferative drug docetaxel (DTX) and a shell coating of the platelet glycoprotein IIb/IIIa receptor monoclonal antibody SZ-21.
A Arsiwala, A Bierhalz, A Tan, AW Heldman, B Almería, B O’brien, B O’Brien, C Stettler, CJ Pan, CJ Sweeney, CL Song, D Sun, DM Saylor, E Boersma, E Camenzind, ES Park, ES Thian, F Danhier, GY An, H Zhang, HG Wang, J Kanzer, J Riegger, J Yang, J Zhang, JB Slee, JJ Wykrzykowska, JM Lee, JV Natarajan, K Kolandaivelu, KH Bønaa, KS Lim, M Gawaz, M Zamani, M Zamani, MK Dong, MP Skinner, MT Ali, PS Douglas, PW Erruys, RH Müller, RK Aggarwal, RL Wilensky, S Freiberg, S Garg, S Hossfeld, S Jang, S Lee, S Mcginty, S Meng, S Puricel, S Yasuda, SJ Liu, T Inoue, T Nakano, TM Ko, U Baber, X Ma, X Wu, X Xi, Y Cao, YH Lee, Z Yang   +62 more
core   +1 more source